Personalized Health Management Platform utilizing Sodium-Dependent Glucose Transporter Inhibitors

The inventive concept integrates Canagliflozin-based pharmaceutical compositions with digital health technologies to provide personalized dietary plans, monitor and control blood glucose levels, and prevent hypoglycemic events.

The original patent disclosed a pharmaceutical composition comprising Canagliflozin, but it did not explore the potential of this technology in digital health applications. This inventive concept addresses the limitations of traditional diabetes management by leveraging the benefits of sodium-dependent glucose transporter inhibitors in personalized health management.

The inventive concept comprises a system for predicting personalized dietary plans, methods for monitoring and controlling blood glucose levels, wearable devices for tracking physical activity and glucose levels, computer-implemented platforms for connecting patients with healthcare providers, and methods for identifying and preventing hypoglycemic events. These components utilize data from Canagliflozin-based pharmaceutical compositions to provide tailored nutritional recommendations, real-time feedback, and personalized alerts.

The new claims introduce a novel application of Canagliflozin-based pharmaceutical compositions in digital health technologies, providing a non-obvious integration of pharmaceutical and digital components to address unmet needs in diabetes management.

Alternative embodiments may include variations in the digital health technologies, such as using artificial intelligence or machine learning algorithms to analyze patient data, or integrating with existing electronic health records systems. Other variations may include using different sodium-dependent glucose transporter inhibitors or expanding the platform to address other health conditions.

The inventive concept has significant commercial potential in the digital health market, particularly in the diabetes management sector. The platform can be marketed to healthcare providers, patients, and payers, offering a comprehensive solution for personalized health management.